Cancer

Items 371-380 of 979

per page
Set Descending Direction
  1. Epacadostat
    CAS  1204669-58-8
    AG-CR1-3634
    AG-CR1-3634-M0055 mg
    CHF 150.00
    AG-CR1-3634-M02525 mg
    CHF 530.00
    Epacadostat
  2. Epoxomicin
    CAS  134381-21-8
    AG-CN2-0422
    AG-CN2-0422-C05050 µg
    CHF 90.00
    AG-CN2-0422-C100100 µg
    CHF 150.00
    AG-CN2-0422-C250250 µg
    CHF 290.00
    AG-CN2-0422-C500500 µg
    CHF 450.00
    Epoxomicin
  3. EPZ015666
    CAS  1616391-65-1
    SYN-3044
    SYN-3044-M0011 mg
    CHF 114.00
    SYN-3044-M0055 mg
    CHF 213.00
    SYN-3044-M01010 mg
    CHF 355.00
    SYN-3044-M05050 mg
    CHF 1'064.00
    SYN-3044-M100100 mgINQ
    EPZ015666
  4. Erlotinib hydrochloride
    CAS  183319-69-9
    SYN-1039
    SYN-1039-M0011 mg
    CHF 71.00
    SYN-1039-M0055 mg
    CHF 99.00
    SYN-1039-M01010 mg
    CHF 128.00
    SYN-1039-M05050 mg
    CHF 170.00
    SYN-1039-M100100 mg
    CHF 206.00
    Erlotinib hydrochloride
  5. Etoposide
    CAS  33419-42-0
    AG-CR1-3572
    AG-CR1-3572-M02525 mg
    CHF 30.00
    AG-CR1-3572-M100100 mg
    CHF 70.00
    AG-CR1-3572-51005 x 100 mg
    CHF 280.00
    Etoposide
  6. Eupatilin
    CAS  22368-21-4
    AG-CN2-0432
    AG-CN2-0432-M0055 mg
    CHF 70.00
    AG-CN2-0432-M02525 mg
    CHF 280.00
    Eupatilin
  7. Euphol
    CAS  514-47-6
    AG-CN2-0541
    AG-CN2-0541-M0011 mg
    CHF 70.00
    AG-CN2-0541-M0055 mg
    CHF 210.00
    AG-CN2-0541-M02525 mg
    CHF 560.00
    Euphol
  8. Everolimus
    CAS  159351-69-6
    AG-CN2-0520
    AG-CN2-0520-M0011 mg
    CHF 40.00
    AG-CN2-0520-M0055 mg
    CHF 75.00
    AG-CN2-0520-M02525 mg
    CHF 195.00
    Everolimus
  9. Everolimus
    CAS  159351-69-6
    CDX-E0074
    CDX-E0074-M100100 mg
    CHF 530.00
    CDX-E0074-M250250 mg
    CHF 1'017.00
    Everolimus
  10. Everolimus Solution
    CAS  159351-69-6
    CDX-E0574
    CDX-E0574-M0011 ml
    CHF 204.00
    Everolimus Solution

Items 371-380 of 979

per page
Set Descending Direction
© 2017 Adipogen Life Sciences. Pictures: © 2012 Martin Oeggerli. All Rights Reserved.